Blood-Brain Barrier (BBB) Market, 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics (2nd Edition) (based on Receptor Mediated Transcytosis, Trojan Horse, and Nanoparticle based Approaches)’ report features an extensive s

Pharmaceuticals

To order this detailed 400+ page report, please visit this link

Key Inclusions

An overview of the

Submitted by Roots_Analysis on 2020-09-02 09:01.

More than 110 drugs, capable of penetrating this elusive barrier are currently being evaluated for the treatment of CNS disorders; there are nearly 35 technology platforms for the development of BBB penetrant drugs, claims Roots Analysis

Market-Research

The concept of BBB penetration is anticipated to bring about a paradigm shift in modern healthcare. In fact, experts believe that there is an important relationship between the recent pandemic of Coronavirus disease (COVID-19) and cerebrovascular system, presenting commercial opportunities

Submitted by Roots_Analysis on 2020-09-02 09:01.

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of BBB penetration technologies and affiliated drugs, over the next decade. The report features an in-depth analysis, highlighting

Pharmaceuticals

Roots Analysis has done a detailed study on Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug ... Read more

Submitted by Roots_Analysis on 2020-09-02 09:00.

The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis

Pharmaceuticals

Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries

Submitted by Roots_Analysis on 2020-09-02 08:52.

The “Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030” report features an extensive study on the contract service providers within the biopharmaceutical industry.

Pharmaceuticals

To order this 750+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-09-02 08:51.

Over 235 companies worldwide claim to offer contract manufacturing services for various types of biopharmaceutical drug / therapy products

Pharmaceuticals

Owing to the ever-increasing number of start-ups that are involved in R&D of novel biologics, there is an enormous opportunity for the CMOs in this domain. It is worth emphasizing that, since 2000, more than 115 new CMOs have been established in order to serve to the growing demand for novel ... Read more

Submitted by Roots_Analysis on 2020-09-02 08:45.

The biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~8%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Biopharma Contract

Submitted by Roots_Analysis on 2020-09-02 08:44.

The biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion in 2030, predicts Roots Analysis

Pharmaceuticals

Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages

Submitted by Roots_Analysis on 2020-09-02 08:43.

Biologics Fill / Finish Service Providers, 2019-2030’ report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry

Pharmaceuticals

To order this detailed 480+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-09-01 12:10.

Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products, claims Roots Analysis

Pharmaceuticals

Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations. Consequently, a number of drug manufacturers have demonstrated ... Read more

Submitted by Roots_Analysis on 2020-09-01 12:09.

The contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%, till 2030

Market-Research

Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030, covering key aspects of the ... Read more

Submitted by Roots_Analysis on 2020-09-01 12:08.

The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis

Market-Research

A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety

Roots Analysis ... Read more

Submitted by Roots_Analysis on 2020-09-01 12:07.

The ‘Antibody Drug Conjugates Market (5th Edition), 2019-2030’ report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.

Pharmaceuticals

To order this detailed 600+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-09-01 12:05.

Presently, over 240 ADC therapy candidates are being evaluated in clinical / preclinical stages for treating a variety of solid tumors / hematologic cancers, claims Roots Analysis

Market-Research

With six marketed drugs, ADCs are presently recognized as a potent class of targeted anticancer therapies, with the potential to be used to treat a variety of other disease indications. The success of such products can be attributed to their ability to effectively identify and eliminate disease ... Read more

Submitted by Roots_Analysis on 2020-09-01 12:01.

The antibody drug conjugates market is projected to grow at an annualized rate of over 20%, till 2030

Market-Research

Roots Analysis has done a detailed report on Antibody Drug Conjugates Market, covering various important aspects of the ... Read more

Submitted by Roots_Analysis on 2020-09-01 12:00.

The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030, predicts Roots Analysis

Market-Research

Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community

Submitted by Roots_Analysis on 2020-09-01 11:59.

The ‘Biologics Fill / Finish Service Providers, 2019-2030’ report

Market-Research

Key Inclusions

A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms

Submitted by Roots_Analysis on 2020-09-01 09:32.

Over 115 companies located in various regions across the globe claim to provide contract fill

Market-Research

Submitted by Roots_Analysis on 2020-09-01 09:29.

The contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%, till 2030

Market-Research

Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030, covering key aspects of the ... Read more

Submitted by Roots_Analysis on 2020-09-01 09:25.

The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030

Market-Research

Roots Analysis ... Read more

Submitted by Roots_Analysis on 2020-09-01 09:21.

Pages